FONAR Corporation (FONR)
- Previous Close
16.01 - Open
16.14 - Bid --
- Ask --
- Day's Range
15.96 - 16.56 - 52 Week Range
12.13 - 24.05 - Volume
17,005 - Avg. Volume
20,841 - Market Cap (intraday)
104.51M - Beta (5Y Monthly) 1.13
- PE Ratio (TTM)
8.80 - EPS (TTM)
1.84 - Earnings Date May 13, 2024 - May 17, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date Mar 18, 1999
- 1y Target Est
--
FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company also offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters, and development and implementation of practice growth and marketing strategies. It owns and operates diagnostic imaging facilities in Florida; and manages MRI scanning facilities. The company markets its scanners to private diagnostic imaging centers and hospital outpatient imaging facilities. FONAR Corporation was founded in 1970 and is based in Melville, New York.
www.fonar.comRecent News: FONR
Performance Overview: FONR
Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: FONR
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: FONR
Valuation Measures
Market Cap
104.51M
Enterprise Value
87.08M
Trailing P/E
8.80
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.05
Price/Book (mrq)
0.64
Enterprise Value/Revenue
0.85
Enterprise Value/EBITDA
2.96
Financial Highlights
Profitability and Income Statement
Profit Margin
12.66%
Return on Assets (ttm)
5.66%
Return on Equity (ttm)
10.94%
Revenue (ttm)
102.42M
Net Income Avi to Common (ttm)
12.36M
Diluted EPS (ttm)
1.84
Balance Sheet and Cash Flow
Total Cash (mrq)
53.26M
Total Debt/Equity (mrq)
22.92%
Levered Free Cash Flow (ttm)
8.7M